Steven Cohen Pmv Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$1.51 - $3.12 $821,889 - $1.7 Million
-544,298 Reduced 72.56%
205,855 $349,000
Q4 2023

Feb 14, 2024
BUY
$1.23 - $6.6 $922,688 - $4.95 Million
750,153 New
750,153 $2.33 Million
Q1 2023

May 15, 2023
BUY
$4.77 - $9.16 $182,109 - $349,710
38,178 New
38,178 $182,000

Others Institutions Holding PMVP

# of Institutions
83
Shares Held
41.9M
Call Options Held
3.1K
Put Options Held
1.7K
View Full List

About PMV Pharmaceuticals, Inc.

PMVP Quotes by TradingView
  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $73.5M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email